M. A. Kaplan Et Al. , "Clinical outcomes in patients who received lapatinib plus capecitabine combination therapy for HER2-positive breast cancer with brain metastasis and a comparison of survival with those who received trastuzumab-based therapy: a study by the Anatolian Society of Medical Oncology," BREAST CANCER , vol.21, no.6, pp.677-683, 2014
Kaplan, M. A. Et Al. 2014. Clinical outcomes in patients who received lapatinib plus capecitabine combination therapy for HER2-positive breast cancer with brain metastasis and a comparison of survival with those who received trastuzumab-based therapy: a study by the Anatolian Society of Medical Oncology. BREAST CANCER , vol.21, no.6 , 677-683.
Kaplan, M. A., Isikdogan, A., Koca, D., KÜÇÜKÖNER, M., Gumusay, O., Yildiz, R., ... Dayan, A.(2014). Clinical outcomes in patients who received lapatinib plus capecitabine combination therapy for HER2-positive breast cancer with brain metastasis and a comparison of survival with those who received trastuzumab-based therapy: a study by the Anatolian Society of Medical Oncology. BREAST CANCER , vol.21, no.6, 677-683.
Kaplan, Muhammet Et Al. "Clinical outcomes in patients who received lapatinib plus capecitabine combination therapy for HER2-positive breast cancer with brain metastasis and a comparison of survival with those who received trastuzumab-based therapy: a study by the Anatolian Society of Medical Oncology," BREAST CANCER , vol.21, no.6, 677-683, 2014
Kaplan, Muhammet A. Et Al. "Clinical outcomes in patients who received lapatinib plus capecitabine combination therapy for HER2-positive breast cancer with brain metastasis and a comparison of survival with those who received trastuzumab-based therapy: a study by the Anatolian Society of Medical Oncology." BREAST CANCER , vol.21, no.6, pp.677-683, 2014
Kaplan, M. A. Et Al. (2014) . "Clinical outcomes in patients who received lapatinib plus capecitabine combination therapy for HER2-positive breast cancer with brain metastasis and a comparison of survival with those who received trastuzumab-based therapy: a study by the Anatolian Society of Medical Oncology." BREAST CANCER , vol.21, no.6, pp.677-683.
@article{article, author={Muhammet Ali Kaplan Et Al. }, title={Clinical outcomes in patients who received lapatinib plus capecitabine combination therapy for HER2-positive breast cancer with brain metastasis and a comparison of survival with those who received trastuzumab-based therapy: a study by the Anatolian Society of Medical Oncology}, journal={BREAST CANCER}, year=2014, pages={677-683} }